CLOSED
GET A PIECE OF HITCHECK
Show more
Mike Piha • Co-Founder, Chief Executive Officer & Board Member
One of Mike's true life passions is coaching youth football. For more than 30 years, he's volunteered his time to coaching and inspiring young athletes, many of which have gone on to play college and professional football.
As co-founder of the NorCal Youth Football league, he has brought the game to more than 7,000 youth and in 2010, Mike was inducted into the American Youth Football Hall of Fame.
Read More
Dr. Jake Benford • Co-Founder & Chief Medical Officer
Jake began his healthcare career in 1988 as an athletic trainer. After working with the NFL's San Francisco 49ers, he knew his true calling was in sports medicine and enrolled in medical school to start the next chapter of his career. In his two decades as an MD, Jake has worked with multiple professional, college, and high school athletic programs including the San Francisco 49ers, the NBA Development-League Santa Cruz Warriors, UCSC, and Cabrillo College.
Dr. Benford's primary occupation is working at CEP America LLC - Vituity (Mercy Emergency). He works 6-10 hours per week at HitCheck.
Read More
Brian Jian, MD, PhD • Chief Medical Advisor
Brian serves as a Neurosurgeon at Kaiser Permanente focusing on Cerebrovascular, Skull Base, Complex Spine, and Deformity.
Brian leads the HitCheck data science and FDA efforts. He has a Bachelor of Arts (BA), Bachelor of Science (BS), Neuroscience and History and Philosophy of Science (HPS), Doctor of Medicine (MD), and Doctor of Philosophy (PhD), Neurosciences from the University of Pittsburgh and University of Pittsburgh School of Medicine Medical School with a residency at University of California San Francisco Neurosurgery.
Read More
***Market statistics provided by Statista and Sports Market Analytics (source / source / source / source)
Aimed at helping athletes, military personnel and active individuals, HitCheck meets the needs of a massive, yet underserved market. The app enables users to collect comprehensive and objective data on their lifelong brain health, which can then be shared with medical professionals, athletic trainers, and health care providers.
*This testimonial may not be representative of the experience of other customers and is not a guarantee of future performance or success.
The Problem
3.8 million sports related concussions occur annually, with many more going undetected. 69% of athletes report having returned to play while experiencing concussion symptoms, and 50% of US Veterans experienced at least one head injury during service. TBIs (traumatic brain injuries) have been identified as one of the signature injuries of troops wounded in Afghanistan and Iraq, with over 430,000 active-duty military TBIs since 2000. In addition to their emotional burden, the economic burden of TBIs in the US is estimated to be approximately $76.5 billion.
Most athletic and military organizations are underserved by using complicated testing methods for head injuries, as they fail to collect valuable data to make critical health decisions. Additionally, most existing assessment tools and practices are either dated and unreliable or extremely costly and require patients to visit a lab or medical clinic.
The Solution
Our patented video game-like cognitive tests track users’ unique brain performance over time, resulting in comprehensive, user-specific data that can be shared with medical professionals, athletic trainers, and health care providers. HitCheck is an FDA 510(k) Exempt Class II Medical Device that can be administered from a smartphone through fun and interactive “brain games” that can be completed in 7 minutes.
Designed to help large organizations prioritize brain health, HitCheck’s easy-to-use dashboard enables teams, schools, leagues and military units to manage the entirety of their players and personnel from one convenient app.
We offer affordable annual subscription plans with various pricing options suitable to organizations of all sizes – averaging about $3.50 annually per subscriber. With strong customer satisfaction and high annual renewal rates, HitCheck delivers a practical solution to the problem of undetected concussions, all for the price of a school lunch.
The Market
Our potential US market consists of 245 million Americans at significant risk of cognitive impairment. This includes 126 million sports team members, 20.6 million military personnel and veterans, and 98 million senior citizens. The global sports technology market is worth $17.9 billion and is expected to reach $40.2 billion by 2026.
While most of our competitors offer tests that must be administered in a clinic, HitCheck is one of the first companies to market a smartphone cognitive assessment aid that provides immediate results. Our comprehensive cognitive assessment tool offers a video game-like, immersive experience that our subscribers love!
Our Traction
HitCheck was registered as an FDA Exempt 510(k) Class II Medical Device in 2017, and the app was launched for IOS and Android at the beginning of 2018. In the summer of 2019, we closed $2.3 million in convertible notes, and we reached 200,000 subscribers; by late 2021, we secured both a patent (US Patent #11154227 B2) and a key partnership with the NFL Alumni Association.
The US Army awarded HitCheck a $108,000 development grant and the US Air Force awarded HitCheck two R&D grants for $50,000 each. Our other notable partnerships include Baylor Scott & White Health Care and Hamilton Health System. Not only do we serve the US Department of Defense, but our app is also used by 5,000+ sports teams and schools such as Texas Youth Football & Cheer, Pepperdine University, Play USA Rugby, and University of Portland.
Why Invest
We believe that HitCheck will become the leading cognitive assessment test on the market, serving athletes, first responders, members of the construction and industrial workforces, veterans and military personnel, among others. We are also currently conducting additional R&D for the US military, pilot-testing a speech analysis add-on and developing a version of the app for the early detection of dementia.
With 245 million Americans at significant risk of cognitive impairment, there is finally a simple solution that allows for early detection and proper treatment!
HitCheck has the potential to help millions of people prevent and delay the effects of degenerative brain diseases, by making it easy to screen for signs of concussion/TBI, and possibly dementia, in minutes. As our subscriber base continues to grow, we couldn’t be more excited for what the future holds. We hope you will join us in leading the way toward better brain health for all!
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Voting Rights of Securities Sold in this Offering
Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.
Investment Incentives and Bonuses*
Time Based
Friends & Family Bonus
Invest in the first 5 days, receive 20% bonus shares
Super-Early Bird Bonus
Invest in the next 5 days, receive 15% bonus shares
Early Bird Bonus
Invest in the first month, receive 10% bonus shares
Amount Based
$500 Tier
Invest $500 and receive 1 year HitCheck subscription for 1 large team (value $159.99)
$1,000 Tier
Invest $1,000 and receive 1 year HitCheck subscription for 2 large teams (value $319.98)
$2,500 Tier
Invest $2,500 and receive 1 year HitCheck subscription 5 large teams (value $499.95)
$5,000 Tier
Invest $5,000 and receive 1 year HitCheck subscription for 1 organization/school with unlimited teams up to 1,500 users (value $3,000)
[Large team = up to 40 users]
*All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
HHITT, Inc. (d/b/a HitCheck) will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $0.53 / share, you will receive 110 Common Stock, meaning you'll own 110 shares for $53. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.
Insider Investment Notice
Officers, directors, executives, and existing owners with a controlling stake in the company (or their immediate family members) may make investments in this offering. Any such investments will be included in the raised amount reflected on the campaign page.
Irregular Use of Proceeds
06.29.22
06.29.22
Thank you for following our journey on Start Engine! This is your final chance to invest in our campaign.
Thank you from the HitCheck Team!
06.28.22
Thank you for following our journey on Start Engine! This is your final chance to invest in our campaign.
Thank you from the HitCheck Team!
06.27.22
Thank you for following our journey on Start Engine! This is your final chance to invest in our campaign.
Thank you from the HitCheck Team!
06.27.22
HitCheck is pleased to announce that Winter Park Resort/Winter Park Competition Center Snowboarding Team is utilizing our patented cognitive assessment tool in their assessment and management of head injuries.
For more information: HitCheck.com
Thanks,
The HitCheck Team
06.26.22
Thank you for following our journey on Start Engine! This is your final chance to invest in our campaign.
Thank you from the HitCheck Team!
06.08.22
We want to thank all of you who invested in HitCheck – Technology to Protect Your Brain!
For those that are still interested in investing, you have until June 29 to invest as little as $249.10. HitCheck is revolutionizing how head injuries are detected with a patented, FDA-registered cognitive assessment aid. Aimed at helping athletes, military personnel, and active individuals, the smartphone app (iOS and Android) enables users to collect comprehensive and objective brain health data over their lifetime. This data can be shared with medical professionals, athletic trainers, and health care providers.
Reasons To Invest:
HitCheck has the potential to help millions prevent and delay the effects of degenerative brain diseases by providing smartphone technology to screen for signs of cognitive decline, in minutes.
Hit back at concussions – invest in HitCheck today!
Thanks,
The HitCheck Team
06.03.22
Again, from our media friends at Physical Therapy Products, HitCheck is in the news about our raise on StartEngine. From the article:
The HitCheck app enables users to collect comprehensive and objective data on their lifelong brain health, which can then be shared with medical professionals, athletic trainers, and health care providers. Investing opportunities are limited and within the first 60 days, HitCheck has raised over $70,000 in committed investments in public funding through the popular StartEngine platform.
“As we continue to evolve through market segments, we are offering the general public the opportunity to invest in HitCheck” says Mike Piha, CEO and Co-Founder. “With millions of active individuals at significant risk of cognitive impairment through sports, military and aging our mobile technology is a game-changer to aid in concussion assessment and brain health. Now is the opportunity to join our team and invest today!”
An estimated 3.8 million sports related concussions occur annually, with many more going undetected. An estimated 69% of athletes report having returned to play while experiencing concussion symptoms, and 50% of US Veterans reported multiple head injuries during service. TBIs (traumatic brain injuries) have been identified as one of the signature injuries of troops wounded in Afghanistan and Iraq, with over 430,000 active-duty military TBIs since 2000. In addition to their emotional burden, the economic burden of TBIs in the US is estimated to be approximately $76.5 billion.
The US market consists of 245 million Americans at significant risk of cognitive impairment including 126 million sports team members, 20.6 million military personnel and veterans, and 98 million Americans Ages 55 years and older.
HitCheck has secured a key partnership with the NFL Alumni Association and proudly serves the US Department of Defense (DoD) through contracts and grants awarded by the Army and Air Force.
The HitCheck app is also patented (US Patent #11154227 B2) and is an FDA-registered Class II Medical Device.
To read the article click here.
Thanks for investing in HitCheck – Technology to protect your brain!
The HitCheck Team
06.02.22
As HitCheck raises funds on StartEngine, our friends in the media continue to publish articles about our successes. Physical Therapy Products published the most recent update:
“HitCheck Receives Air Force SBIR Contract”
HitCheck, a mobile app that health care providers and athletic trainers use as a cognitive assessment tool, has been awarded a Phase II Small Business Innovation Research (SBIR) contract by AFWERX (a United States Air Force program with the goal of fostering innovation within the service).
The contract will be performed with the 59th Medical Wing, San Antonio Military Medical Center, Department of Orthopedics.
“We are honored to continue our work with the US Department of Defense through this SBIR Phase II contract,” said HitCheck Co-Founder/CEO, Mike Piha. “Our mobile cognitive assessment technology will enhance the neurological health and well-being of Airmen and ensure peak performance to support warfighter readiness while utilizing a personal smartphone.”
HitCheck was selected by the DoD for a $1.25 Million award to develop its cognitive assessment aid for the US Air Force. HitCheck will work closely with its Air Force partner on the mission impact for the Air Force and the DoD to provide a customized mobile, deployable concussion solution to aid in Airmen’s concussion screening, recovery and fulfill a high priority medical capability gap to deployed servicemen. The goal of the project is to deploy HitCheck as a telemedicine platform to Airmen to provide remote concussion assessment capabilities.
This is the fourth US Military award for HitCheck, following two previous SBIR Phase I awards and a US Army contract developing the “HHITT Military” app for a clinical trial.
You can read the full article “HitCheck Receives Air Force SBIR Contract” here.
Developing technology to improve brain health is the mission of HitCheck.
Join us today to further our mission – invest today!
Thanks,
The HitCheck Team
05.12.22
The US military utilizes a cognitive assessment tool for all service members that sustain a head injury. The Military Acute Concussion Evaluation 2 (MACE 2) is used to identify symptoms of a mild traumatic brain injury (mTBI) at the point of injury or care. People who experience mTBI, also referred to as concussion, have symptoms that may include headache, confusion, lack of coordination, memory loss, nausea, vomiting, dizziness, ringing in the ears, sleep problems, and excessive fatigue.
HitCheck digitized MACE 2 for the Department of Defense (DoD) through a contract with the US Army. We will incorporate the required MACE 2 in a new smartphone application that is being developed through a $1.25M contract with the US Air Force. HitCheck will utilize MACE 2 alongside its patented 9-test cognitive assessment tool.
For more information about MACE 2, you can read the article “Immediate Testing: How the Military Evaluates Risk For Brain Injuries” here.
Invest today in the brain health of US service members!
Thanks,
The HitCheck Team
Venture Club
Venture Club Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).
$500 Tier
Invest $500 and receive 1 year HitCheck subscription for 1 large team (value $159.99)
$1,000 Tier
Invest $1,000 and receive 1 year HitCheck subscription for 2 large teams (value $319.98)
$2,500 Tier
Invest $2,500 and receive 1 year HitCheck subscription 5 large teams (value $499.95)
$5,000 Tier
Invest $5,000 and receive 1 year HitCheck subscription for 1 organization/school with unlimited teams up to 1,500 users (value $3,000)
0/2500
3 years ago
Show more
1
0
3 years ago
Show more
1
0
3 years ago
Show more
1
0
3 years ago
Show more
2
1
Cancel anytime before 48 hours before a rolling close or the offering end date.
We want you to succeed and get the most out of your money by offering rewards and memberships!
Your info is your info. We take pride in keeping it that way!
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
Latoya Freeman
3 years ago
Hi, congrats on your achievements to date and very much needed product. I've reviewed the form C and have a couple of questions. 1. You mention competitors, it seems your only USP is the mobile app. But you also mention one that's on an ipad, to me that's a mobile assessment. Can you please explain your USP and patent in layman's terms and what can't be copied. 2. Why crowdfund? It seems you've raised $3M+ to date and have an opportunity for over $2.5M in government funds in the future. So, with modest CF traction in the first 30 days, why crowdfund? (I'll note the CF valuation is similar to your $400k private equity round, so no concerns on valuation.) 3.Which leads to my next question of the burn rate. You proved the proof of concept, but revenues are still modest. Per form C, profitablity is not in the near 3-5 years. So what's needed to start to increase revenue month-over'month, or is that not the focus at this time? Thanks for your time and to your success!
Show more
1
0